Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Aptevo Therapeutics Inc. shares fell 11.9% to $4.52 in pre-market trading. The company experienced an 82% increase on Wednesday post-clinical data announcement. Market overall was lower, with Dow futures down 0.2% this morning. Other biotech stocks also showed declines during pre-market trading. Smith & Wesson's disappointing earnings report affected overall market sentiment.
View signal analysis